Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Cureus ; 16(3): e55481, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38571849

RESUMEN

One of the rarest types of ectopic pregnancy, with an incidence of 1:1,800, is cesarean scar ectopic pregnancy. Here, we report the case of a 28-year-old woman who had undergone two previous cesarean sections. She arrived at our labor room with per vaginal spotting and abdominal pain with an ultrasound that revealed a cesarean scar ectopic pregnancy. The initial beta-human chorionic gonadotropin (ß-hCG) value upon admission was 27,133 mIU/mL. Her ultrasound findings were confirmed with magnetic resonance imaging. Opting for combined medical management, we successfully treated her using systemic methotrexate and mifepristone, avoiding surgical intervention despite high ß-hCG values. There is currently no established standardized treatment for cesarean scar ectopic pregnancies, and we feel that treatment must be tailored to every patient's individual needs. Our experience suggests that combining mifepristone and systemic methotrexate can be an effective approach with better curative effects, emphasizing the need for further research.

2.
Cureus ; 16(1): e53264, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38435960

RESUMEN

Recurrent pregnancy loss, premature birth, and associated complications exhibit a multifactorial etiology and persist as substantial challenges during pregnancy, despite the notable advancements in the medical field. Among several factors, cervical insufficiency or incompetence emerges as a prominent causal factor, characterized by painless softening and shortening of the cervix associated with absent contractions. The implementation of emergency cerclage represents a pivotal intervention in mitigating preterm birth among individuals with advanced cervical insufficiency. By extending gestational age, this procedure increases the likelihood of neonatal survival without elevating the risk of chorioamnionitis or preterm rupture of the membranes. In this study, an antenatal woman presented with advanced changes in the cervix along with intravaginal bulging amniotic membranes at 18 weeks and underwent a rescue cervical cerclage, resulting in a successful pregnancy.

3.
Cureus ; 15(2): e35377, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36987486

RESUMEN

An actual knot that forms during pregnancy is known as a true knot of the umbilical cord (TKUC) which is seen in 0.3% to 1.2% of pregnancies. TKUC is noteworthy because it can lead to a variety of adverse perinatal outcomes, including infants with low Apgar scores, small for gestational age (SGA) fetuses, fetal hypoxia, and also in some cases fetal death. Here, we present instances of TKUC of three patients and the various associated perinatal outcomes.

4.
N Biotechnol ; 26(6): 282-8, 2009 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-19666150

RESUMEN

We report a simple and cost-effective autoinducible media component responsible for the autoinduction of proteins in Escherichia coli under lacUV5 promoter system. Yeast extract (YE) at high concentration was found to stimulate the expression of T7 RNA polymerase in BL21(DE3) cells while such an effect was not seen in BL21A1 cells. A systematic study on the effect of varying concentrations of YE indicated several folds higher expression of genes viz., human granulocyte colony stimulating factor (rhGCSF), human interferon alpha 2b (rhIFN-alpha2b) and Staphylokinase (rSAK) in BL21(DE3) cells in the absence of any specific inducer like IPTG or additional lactose. Additional investigations on the inducible component of the YE revealed the presence of significant amount of endogenous lactose as the contributory factor for the observed autoinduction phenomenon. This paper highlights the easy scalability of the use of the present media component for large-scale production in biotechnology industry.


Asunto(s)
Escherichia coli/genética , Regulación Bacteriana de la Expresión Génica , Regiones Promotoras Genéticas , Saccharomyces cerevisiae/metabolismo , Medios de Cultivo/farmacología , AMP Cíclico/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Glucosa/metabolismo , Factor Estimulante de Colonias de Granulocitos/metabolismo , Humanos , Interferón alfa-2 , Interferón-alfa/metabolismo , Lactosa/metabolismo , Metaloendopeptidasas/metabolismo , Proteínas Recombinantes , Saccharomyces cerevisiae/efectos de los fármacos , Solubilidad/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...